Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Expert phone call may save lives in bleeding emergencies

NCT ID NCT05928091

Knowledge-focused Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether having a specialist give advice by phone during emergencies helps patients with severe bleeding who take blood thinners. About 1,000 patients will be treated either with standard care or with added expert guidance. Researchers will compare how well bleeding is controlled and track complications over 3 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that getting expert advice during emergencies leads to better care and fewer complications for patients on blood thinners.
What could go wrong
This is an early-stage study testing a process, not a new drug. Results may not apply to all hospitals or patients, and the benefit may be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2023

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Major patient treated with oral anticoagulants, admitted in an emergency department * For suspected major bleeding defined according to the criteria of the International Society of Thrombosis and Haemostasis * Able to give informed consent to participate in research or, in the event of an emergency, to take charge of a reference person * Affiliated to a Social Security scheme. Exclusion Criteria: * Pregnant or breastfeeding women * Patient under guardianship, curatorship or safeguard of justice * Administration within the last 24 hours of parenteral anticoagulant. * Refusal to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemorrhage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemorrhage

Contacts and locations

Locations

  • CH Aurillac

    Aurillac, 15000, France

  • CH Le Puy

    Le Puy-en-Velay, 43000, France

  • CH Montluçon

    Montluçon, 03000, France

  • CH de Montbrison

    Montbrison, 42600, France

  • CH de Moulins

    Moulins, 03000, France

  • CH de Vichy

    Vichy, 03200, France

  • CHR Orléans

    Orléans, 45000, France

  • CHU Grenoble

    Grenoble, 38000, France

  • CHU Tours

    Tours, 37000, France

  • CHU de Clermont-Ferrand

    Clermont-Ferrand, 63000, France

  • CHU de Nice

    Nice, 06000, France

  • CHU de Saint-Etienne

    Saint-Etienne, 42000, France

  • CHU de Toulouse

    Toulouse, 31000, France

  • Hospice civils de Lyon

    Lyon, 69000, France

  • La Pitié-Salpétrière

    Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.